Could maintenance topical tacrolimus treatment be regarded as a new therapeutic option in atopic dermatitis?

被引：0
|
作者：
Narbutt, Joanna [1 ]
Zakrzewski, Marcin [1 ]
Lesiak, Aleksandra [1 ]
机构：
[1] Uniwersytetu Med Lodzi, Klin Dermatol & Wenerol, Ul Krzemieniecka 5, PL-94017 Lodz, Poland
来源：
PRZEGLAD DERMATOLOGICZNY | 2009年 / 96卷 / 03期
关键词：
atopic dermatitis; tacrolimus; maintenance treatment;
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
Atopic dermatitis (AD) is a chronic skin disease in which pathogenesis genetic and immunological disturbances are involved. Commonly, AD treatment includes: emollients, topical anti-inflammatory medications and, in severe cases, photo(chemo) therapy or systemic immunosuppressants. Recent literature data indicate the efficacy of maintenance treatment of AD with local tacrolimus applied 2-3 times weekly for several months. In the article current knowledge on this new therapeutic option is described. Moreover, controversies concerning safety of topical calcineurin inhibitors are discussed.
引用
收藏
页码：235 / 239
页数：5
相关论文
共 50 条
  • [31] Atopic dermatitis - Tacrolimus vs topical corticosteroid use
    langa, Yolande
    SA PHARMACEUTICAL JOURNAL, 2010, 77 (10) : 50 - 56
  • [32] Topical treatment of atopic dermatitis
    Boguniewicz, M
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2004, 24 (04) : 631 - +
  • [33] Development of new topical substances for the treatment of atopic dermatitis
    Freimooser, Sina
    Traidl, Stephan
    Werfel, Thomas
    DERMATOLOGIE, 2022, 73 (07): : 514 - 519
  • [34] Tacrolimus-loaded chitosan-based nanoparticles as an efficient topical therapeutic for the effective treatment of atopic dermatitis symptoms
    Lee, Jin Sil
    Oh, Eunjeong
    Oh, Hyeryeon
    Kim, Sunghyun
    Ok, Subin
    Sa, Junseo
    Lee, Jeung-Hoon
    Shin, Yong Chul
    Bae, Yong-Soo
    Choi, Cheol Yong
    Lee, Sangho
    Kwon, Ho-Keun
    Yang, Siyoung
    Choi, Won Il
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 273
  • [35] Effect of infosheet for topical tacrolimus 0.1% and its efficacy and compliance in the treatment of atopic dermatitis
    Han, Ji Su
    Lee, Woo Jin
    Ko, Joo Yeon
    Kim, Joung Soo
    Kim, Sang Seok
    Seo, Soo Hong
    Lew, Bark-Lynn
    Lee, Ga-Young
    Lee, Ju Hee
    Park, Chang Ook
    Jang, Sang Jai
    Park, Hyun Soo
    Hong, Seung Phil
    Chang, Sung Eun
    Lee, Mi Woo
    Choi, Jee Ho
    Moon, Kee Chan
    Won, Chong Hyun
    ALLERGY ASTHMA & RESPIRATORY DISEASE, 2013, 1 (03): : 221 - 226
  • [36] Atopic dermatitis: tacrolimus vs. topical corticosteroid use
    Langa, Y.
    Van der Merwe, E.
    SA PHARMACEUTICAL JOURNAL, 2016, 83 (03) : 11 - +
  • [37] Topical Sildenafil in Comparison with Tacrolimus on Induced Atopic Dermatitis in Mice
    Shallal, Amna Muntaser
    JOURNAL OF PHARMACEUTICAL NEGATIVE RESULTS, 2022, 13 : 19 - 28
  • [38] Topical Vardenafil in Comparison with Tacrolimus on Induced Atopic Dermatitis in Mice
    Muhammed, Omer Farooq
    JOURNAL OF PHARMACEUTICAL NEGATIVE RESULTS, 2022, 13 : 7 - 11
  • [39] Atopic dermatitis: tacrolimus vs. topical corticosteroid use
    Langa, Y.
    Van der Merwe, E.
    SOUTH AFRICAN FAMILY PRACTICE, 2011, 53 (04) : 340 - 346
  • [40] Adherence to topical tacrolimus 0.1% ointment in children with atopic dermatitis
    Yentzer, Brad
    Clark, Adele
    Williams, Lisa
    Sagransky, Matthew
    Feldman, Steven
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 62 (03) : AB46 - AB46
12345